Why daratumumab will become key for the treatment of multiple myeloma
How can standard risk multiple myeloma (MM) patients be cured?
The importance of the microenvironment in multiple myeloma
Why patients should be involved in evaluating novel drugs in multiple myeloma
Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.